학술논문

Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; OCT 2019, 30 2p. Supplement: 5
Subject
Language
English
ISSN
15698041